Literature DB >> 36239848

A Matched-Pair Analysis of Nuclear Morphologic Features Between Core Needle Biopsy and Surgical Specimen in Thyroid Tumors Using a Deep Learning Model.

Faridul Haq1,2, Andrey Bychkov3, Chan Kwon Jung4,5,6,7.   

Abstract

Core needle biopsy (CNB) is a method that can be used as an alternative to fine-needle aspiration for the sampling of thyroid nodules to provide a preoperative diagnosis. Nuclear atypia is of paramount importance in diagnosing thyroid tumors. We aimed to identify the differences in nuclear morphologic features between CNB and surgical specimens. Quantitative image analysis was performed on whole slide images (WSI) of paired CNB and surgical specimens from 50 follicular cell-derived tumors including adenoma, non-invasive follicular thyroid neoplasm with papillary-like nuclear features, and carcinoma. The nuclear features of tumor cells were extracted from WSI using a pre-trained deep-learning model. In matched-pair analysis, the ratios (surgical specimens-to-CNB) of the mean nuclear diameters and the areas of the tumor cells were 1:0.75-0.85 and 1:0.54-0.73 according to the tumor types, respectively. The ratio of the nuclear optical density of tumor cells was 1.68-2.44 times higher in CNB specimens than it was in their corresponding surgical specimens. The significant nuclear size reduction and optical density increase in CNB were most prominent in papillary carcinoma cells. Normal follicular cells showed nuclear size reduction in CNB but no change in nuclear optical density between CNB and surgical specimens. Nuclear vacuolar artifacts mimicking nuclear pseudoinclusions were frequently seen in CNB regardless of the tumor types. In conclusion, tumor cells in CNB showed marked nuclear shrinkage, darker nuclear staining, and nuclear vacuolar changes. Awareness of the morphological differences according to the sampling types can facilitate correct diagnosis in thyroid histopathology.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biopsy; Deep learning; Digital pathology; Image analysis; Morphometry; Thyroid neoplasms

Year:  2022        PMID: 36239848     DOI: 10.1007/s12022-022-09733-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  25 in total

Review 1.  Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Gary L Francis; Steven G Waguespack; Andrew J Bauer; Peter Angelos; Salvatore Benvenga; Janete M Cerutti; Catherine A Dinauer; Jill Hamilton; Ian D Hay; Markus Luster; Marguerite T Parisi; Marianna Rachmiel; Geoffrey B Thompson; Shunichi Yamashita
Journal:  Thyroid       Date:  2015-07       Impact factor: 6.568

Review 2.  The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis.

Authors:  Massimo Bongiovanni; Alessandra Spitale; William C Faquin; Luca Mazzucchelli; Zubair W Baloch
Journal:  Acta Cytol       Date:  2012-07-25       Impact factor: 2.319

Review 3.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

4.  Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: A systematic review and meta-analysis.

Authors:  Huy Gia Vuong; Hanh Thi Tuyet Ngo; Andrey Bychkov; Chan Kwon Jung; Trang Huyen Vu; Kim Bach Lu; Kennichi Kakudo; Tetsuo Kondo
Journal:  Cancer Cytopathol       Date:  2019-12-28       Impact factor: 5.284

5.  Risk of Malignancy According to the Sub-classification of Atypia of Undetermined Significance and Suspicious Follicular Neoplasm Categories in Thyroid Core Needle Biopsies.

Authors:  Sae Rom Chung; Jung Hwan Baek; Jeong Hyun Lee; Yu-Mi Lee; Tae-Yon Sung; Ki-Wook Chung; Suck Joon Hong; Min Ji Jeon; Tae Yong Kim; Young Kee Shong; Won Bae Kim; Won Gu Kim; Dong Eun Song
Journal:  Endocr Pathol       Date:  2019-06       Impact factor: 3.943

6.  The incidence of thyroid cancer by fine needle aspiration varies by age and gender.

Authors:  Laurel J Bessey; Ngan Betty K Lai; Nicholas E Coorough; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2013-04-17       Impact factor: 2.192

7.  Comparison of Consecutive Results from Fine Needle Aspiration and Core Needle Biopsy in Thyroid Nodules.

Authors:  Soon-Hyun Ahn; So-Yeon Park; Sang Il Choi
Journal:  Endocr Pathol       Date:  2017-12       Impact factor: 3.943

8.  The Use of the Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: A Meta-Analysis.

Authors:  Huy Gia Vuong; Duy Giang Bao Chung; Luan Minh Ngo; Thien Quoc Bui; Lewis Hassell; Chan Kwon Jung; Kennichi Kakudo; Andrey Bychkov
Journal:  Thyroid       Date:  2021-03-04       Impact factor: 6.568

9.  The use of core needle biopsy as first-line in diagnosis of thyroid nodules reduces false negative and inconclusive data reported by fine-needle aspiration.

Authors:  Pierpaolo Trimboli; Naim Nasrollah; Leo Guidobaldi; Silvia Taccogna; Davide Domenico Cicciarella Modica; Stefano Amendola; Francesco Romanelli; Andrea Lenzi; Giuseppe Nigri; Marco Centanni; Luca Giovanella; Stefano Valabrega; Anna Crescenzi
Journal:  World J Surg Oncol       Date:  2014-03-24       Impact factor: 2.754

Review 10.  2019 Practice guidelines for thyroid core needle biopsy: a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association.

Authors:  Chan Kwon Jung; Jung Hwan Baek; Dong Gyu Na; Young Lyun Oh; Ka Hee Yi; Ho-Cheol Kang
Journal:  J Pathol Transl Med       Date:  2020-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.